Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Stock Has Average Price Target of $28.38

Shares of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) have been given an average rating of “Hold” by the seven ratings firms that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, two have given a hold rating and four have given a buy rating to the company. The average 1 year price target among brokers that have covered the stock in the last year is $28.38.

KMTS has been the subject of several research analyst reports. Piper Sandler restated an “overweight” rating on shares of Kestra Medical Technologies in a research report on Tuesday, September 15th. Royal Bank Of Canada set a $30.00 price objective on Kestra Medical Technologies in a report on Tuesday, September 15th. BTIG Research reissued a “buy” rating and set a $32.00 target price on shares of Kestra Medical Technologies in a report on Tuesday, September 15th. Wall Street Zen downgraded Kestra Medical Technologies from a “hold” rating to a “sell” rating in a research report on Saturday, September 12th. Finally, Wolfe Research set a $30.00 price target on Kestra Medical Technologies in a research note on Wednesday, July 15th.

Insider Buying and Selling

In other Kestra Medical Technologies news, insider Traci Umberger sold 8,752 shares of Kestra Medical Technologies stock in a transaction on Friday, July 31st. The shares were sold at an average price of $22.60, for a total transaction of $197,795.20. Following the sale, the insider owned 206,995 shares of the company’s stock, valued at $4,678,087. The trade was a 4.06% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Timothy Moran sold 8,759 shares of the stock in a transaction dated Friday, July 31st. The shares were sold at an average price of $22.61, for a total transaction of $198,040.99. Following the completion of the sale, the insider owned 68,725 shares of the company’s stock, valued at $1,553,872.25. This trade represents a 11.30% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 246,928 shares of company stock worth $5,997,473 in the last ninety days. Company insiders own 5.30% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in KMTS. Corient Private Wealth LP raised its position in shares of Kestra Medical Technologies by 284.2% during the 2nd quarter. Corient Private Wealth LP now owns 60,614 shares of the company’s stock valued at $1,542,000 after buying an additional 44,839 shares during the period. California State Teachers Retirement System grew its position in Kestra Medical Technologies by 39.2% in the first quarter. California State Teachers Retirement System now owns 27,835 shares of the company’s stock worth $555,000 after acquiring an additional 7,844 shares during the period. The Manufacturers Life Insurance Company increased its stake in Kestra Medical Technologies by 6.6% during the first quarter. The Manufacturers Life Insurance Company now owns 92,515 shares of the company’s stock worth $1,844,000 after acquiring an additional 5,731 shares during the last quarter. Quantinno Capital Management LP acquired a new stake in Kestra Medical Technologies during the first quarter worth $431,000. Finally, Sei Investments Co. raised its holdings in Kestra Medical Technologies by 22.6% in the 1st quarter. Sei Investments Co. now owns 237,116 shares of the company’s stock valued at $4,726,000 after buying an additional 43,753 shares during the period.

Kestra Medical Technologies Trading Down 4.4%

Shares of NASDAQ:KMTS opened at $27.10 on Friday. The business’s 50 day moving average price is $26.01 and its 200-day moving average price is $23.15. Kestra Medical Technologies has a 1 year low of $17.34 and a 1 year high of $30.00. The firm has a market capitalization of $1.61 billion, a price-to-earnings ratio of -10.15 and a beta of 0.51. The company has a debt-to-equity ratio of 0.33, a current ratio of 4.69 and a quick ratio of 4.69.

Kestra Medical Technologies (NASDAQ:KMTS) last issued its quarterly earnings results on Monday, September 14th. The company reported ($0.75) EPS for the quarter, missing the consensus estimate of ($0.61) by ($0.14). The company had revenue of $30.97 million during the quarter. Kestra Medical Technologies had a negative return on equity of 63.83% and a negative net margin of 140.43%. On average, equities research analysts forecast that Kestra Medical Technologies will post -2.45 earnings per share for the current fiscal year.

About Kestra Medical Technologies

Kestra Medical Technologies, Inc is a medical device company focused on developing and commercializing technologies designed to help protect patients at risk of sudden cardiac arrest. The company’s primary product is the ASSURE wearable cardioverter defibrillator, or WCD, which is intended to provide temporary protection for patients who may be at elevated risk of life-threatening ventricular arrhythmias.

The ASSURE system continuously monitors a patient’s heart rhythm and is designed to detect potentially dangerous arrhythmias, including ventricular tachycardia and ventricular fibrillation.